Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

531 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I study of tamibarotene monotherapy in pediatric and young adult patients with recurrent/refractory solid tumors.
Nitani C, Hara J, Kawamoto H, Taguchi T, Kimura T, Yoshimura K, Hamada A, Kitano S, Hattori N, Ushijima T, Ono H, Nakamoto M, Higuchi T, Sato A. Nitani C, et al. Among authors: hara j. Cancer Chemother Pharmacol. 2021 Jul;88(1):99-107. doi: 10.1007/s00280-021-04271-9. Epub 2021 Apr 7. Cancer Chemother Pharmacol. 2021. PMID: 33829292 Clinical Trial.
Autologous Stem Cell Transplantation for Children With Renal Tumors, and Adults With Wilms Tumor: Retrospective Analysis of the Japanese Transplant Registry Unified Management Program.
Kobayashi R, Inoue M, Takahashi Y, Kikuta A, Ogawa A, Koga Y, Koh K, Hashii Y, Hara J, Kato K, Tabuchi K, Matsumoto K. Kobayashi R, et al. Among authors: hara j. J Pediatr Hematol Oncol. 2020 May;42(4):251-255. doi: 10.1097/MPH.0000000000001779. J Pediatr Hematol Oncol. 2020. PMID: 32134841
Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors.
Tsuchiya N, Hosono A, Yoshikawa T, Shoda K, Nosaka K, Shimomura M, Hara J, Nitani C, Manabe A, Yoshihara H, Hosoya Y, Kaneda H, Kinoshita Y, Kohashi K, Yoshimura K, Fujinami N, Saito K, Mizuno S, Nakatsura T. Tsuchiya N, et al. Among authors: hara j. Oncoimmunology. 2017 Sep 27;7(1):e1377872. doi: 10.1080/2162402X.2017.1377872. eCollection 2017. Oncoimmunology. 2017. PMID: 29296538 Free PMC article.
Pharmacokinetics of thiotepa in high-dose regimens for autologous hematopoietic stem cell transplant in Japanese patients with pediatric tumors or adult lymphoma.
Kondo E, Ikeda T, Goto H, Nishikori M, Maeda N, Matsumoto K, Kitagawa H, Noda N, Sugimoto S, Hara J. Kondo E, et al. Among authors: hara j. Cancer Chemother Pharmacol. 2019 Oct;84(4):849-860. doi: 10.1007/s00280-019-03914-2. Epub 2019 Aug 19. Cancer Chemother Pharmacol. 2019. PMID: 31428821 Free PMC article. Clinical Trial.
Outcome of TCF3-PBX1 positive pediatric acute lymphoblastic leukemia patients in Japan: a collaborative study of Japan Association of Childhood Leukemia Study (JACLS) and Children's Cancer and Leukemia Study Group (CCLSG).
Asai D, Imamura T, Yamashita Y, Suenobu S, Moriya-Saito A, Hasegawa D, Deguchi T, Hashii Y, Endo M, Hatakeyama N, Kawasaki H, Hori H, Horibe K, Yumura-Yagi K, Hara J, Watanabe A, Kikuta A, Oda M, Sato A; Japan Association of Childhood Leukemia Study (JACLS) & Children's Cancer and Leukemia Study Group (CCLSG). Asai D, et al. Among authors: hara j. Cancer Med. 2014 Jun;3(3):623-31. doi: 10.1002/cam4.221. Epub 2014 Feb 28. Cancer Med. 2014. PMID: 24578304 Free PMC article.
Pharmacokinetics, efficacy, and safety of caspofungin in Japanese pediatric patients with invasive candidiasis and invasive aspergillosis.
Mori M, Imaizumi M, Ishiwada N, Kaneko T, Goto H, Kato K, Hara J, Kosaka Y, Koike K, Kawamoto H, Maeda N, Yoshinari T, Kishino H, Takahashi K, Kawahara S, Kartsonis NA, Komada Y. Mori M, et al. Among authors: hara j. J Infect Chemother. 2015 Jun;21(6):421-6. doi: 10.1016/j.jiac.2015.01.009. Epub 2015 Jan 30. J Infect Chemother. 2015. PMID: 25701307
531 results